The pharmaceutical companies with the most patents in the last quarter of 2023 have been identified based on their activity in the sector. F. Hoffmann-La Roche led the chart with 523 patents filed, followed by Zhejiang University with 426 patents, and Johnson & Johnson with 378 patents. The data reflects the ongoing efforts by these companies to innovate and protect their research outcomes. The bulk of the patent filings in the pharmaceutical industry were in China, accounting for 38% of the total, followed by the US with 14% and Japan with 7%​​.
In terms of global presence and influence, companies like Roche, Novartis, and Merck & Co. are among the top pharmaceutical companies. Roche and Novartis, both Swiss multinational companies, continue to make significant impacts in the field with their groundbreaking medicines and strong global presence. Merck & Co., known for its contributions to diabetes and cancer care, has been moving up the ranks, largely propelled by their blockbuster cancer immunotherapy, Keytruda​​.
The top pharmaceutical companies with the most patents in Q4 2023, based on the number of patents filed, are:
- F. Hoffmann-La Roche: Leading with 523 patents, known for their significant contributions to healthcare and medicine​​.
- Zhejiang University: Followed with 426 patents, showing the growing influence of academic institutions in pharmaceutical innovations​​.
- Johnson & Johnson: Secured third place with 378 patents, a testament to their broad research and development capabilities​​.
These companies are not only leaders in patent filings but also play crucial roles in medical research and the development of new drugs and therapies. For detailed information on their patent activities and impacts on the pharmaceutical industry, you can visit sources like Pharmaceutical Technology.